Bruno Randi, MD, PhD
banner
brunorandimd.bsky.social
Bruno Randi, MD, PhD
@brunorandimd.bsky.social
ID physician, especially interested in infections among HSCT patients
São Paulo, Brasil 🇧🇷
#TxID #IDOnc #IDSky
Reposted by Bruno Randi, MD, PhD
New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on administering age-appropriate Influenza and RSV vaccinations in populations with compromised immunity. https://www.idsociety.org/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/
November 4, 2025 at 10:13 PM
Reposted by Bruno Randi, MD, PhD
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study

✅ Just Accepted
#IDSky
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study
In this study of 172 ICU patients with influenza-related ARDS, empirical antifungal treatment was associated with reduced pulmonary aspergillosis incidence
bit.ly
September 23, 2025 at 5:22 PM
🚨 Preliminary results! 🚨 Our systematic review & meta-analysis on stopping quinolone prophylaxis pre-engraftment in HSCT — just presented at the XXIV Brazilian Congress of Infectious Diseases.

#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
September 18, 2025 at 6:35 PM
Outstanding talk by @jobadd.bsky.social at the XXIV Brazilian Congress of Infectious Diseases on invasive fungal infections in solid organ transplantation!
#IDSky #TxID #InfectiousDiseases
September 18, 2025 at 6:34 PM
Reposted by Bruno Randi, MD, PhD
Do AMS really work in transplant units and what is yet to be done?

Happy to share our systematic review in @eclinicalmed.bsky.social which we hope will support AB stewardship implementation in SOT units and future research steps #AMSsky #TxID #IDsky

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
July 4, 2025 at 3:41 AM
Reposted by Bruno Randi, MD, PhD
🎙️ Just published a new #Communicable episode: Communicable E28: Late-breaker trials at ESCMID Global: Should they change ...

Hosted by Josh Davis @gurujosh.bsky.social
Erin McCreary @erinmccreary.bsky.social
Emily McDonald @dremilymcd.bsky.social

Listen here:

#IDSky #Clinmicro #MedSky
Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2
Editors of CMI Comms, Josh Davis, Erin McCreary and Emily McDonald...
share.transistor.fm
June 1, 2025 at 10:01 PM
Reposted by Bruno Randi, MD, PhD
【Hepatic Mucormycosis】
Excited to share our latest review on hepatic mucormycosis!

👉N=40, 1990-2025
👉histopathology (73%), culture positivity was low (36%)

Big congratulations to Hazim for leading the effort!

@mdanderson.bsky.social @msgerc.bsky.social
www.mdpi.com/2309-608X/11...
May 27, 2025 at 2:43 PM
Can we safely proceed with HSCT after COVID-19? 🤔🧬

Our new study says yes ✅ — overall survival is unchanged.

But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫

📄 Read more: doi.org/10.1038/s414...

#HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID
May 25, 2025 at 9:10 PM
Reposted by Bruno Randi, MD, PhD
Updated #IDSAGuidelines! IDSA Guidelines on Histoplasmosis Treatment: Focused Update on Asymptomatic Histoplasma Pulmonary Nodules and Mild or Moderate Acute Pulmonary Histoplasmosis are out now: buff.ly/vHZV7YQ
May 24, 2025 at 4:04 PM
We previously reported a case of fatal hepatic mucormycosis after Haplo-HSCT
⚠️ Hepatic abscess - sequencing: Mucor indicus
💉 Early liposomal amphotericin B wasn't enough
📉 Literature review: 24 cases; 50.0% multiple lesions; mortality rate 45.8%
Full text: www.jiac-j.com/article/S134...
#IDSky #TxID
April 30, 2025 at 12:20 AM
Reposted by Bruno Randi, MD, PhD
Excited to share the updated CDC yellow book chapter on Immunocompromised Host and travel, here is the official updated website from the CDC. Let me know if you have questions or comments. www.cdc.gov/yellow-book/...
Immunocompromised Travelers
Tailor vaccine and medicine recommendations based on international travelers’ immune systems.
www.cdc.gov
April 26, 2025 at 3:35 PM
Reposted by Bruno Randi, MD, PhD
Blood virome after allogeneic hematopoietic stem cell transplantation

✅ Just Accepted
#IDSky
Blood virome after allogeneic hematopoietic stem cell transplantation
Haploidentical allogeneic hematopoietic cell transplantation recipients (allo-HCTr) receiving post-transplant cyclophosphamide (haplo-PTCy) are at higher risk for viral infections.
doi.org
April 21, 2025 at 2:33 PM
🚨 Measles cases are rising — stay alert, especially for immunocompromised patients.

Our group published data showing MMR after HSCT may be safe from 12 months post-Tx (if no GVHD or immunosuppression).

📰 Full article: pmc.ncbi.nlm.nih.gov/articles/PMC...

#Measles #MMR #Vaccination #HSCT #IDSky
April 20, 2025 at 9:16 PM
Reposted by Bruno Randi, MD, PhD
A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal
April 12, 2025 at 7:48 AM
Reposted by Bruno Randi, MD, PhD
One week left to register for this exclusive global health session featuring leading experts reviewing the latest developments in diagnostics, treatment strategies, and challenges in immunocompromised populations.

Register Here: www.ichs.org/event-6069138
April 17, 2025 at 10:38 AM